Quick Takeaways
- Dellora Investments LP filed SCHEDULE 13G/A for PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value (PVLA).
- Disclosed ownership: 1.3%.
- Date of event: 13 Dec 2024.
Dellora Investments LP - 13 Dec 2024 SCHEDULE 13G/A Report for PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value (PVLA)
- Filing Manager
- Dellora Investments LP
- Reporting Manager
- Dellora Investments LP
- Symbol
- PVLA
- Shares outstanding
- 10,852,231 shares
- Disclosed Ownership
- 141,079 shares
- Ownership
- 1.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Dec 2024, 16:22:06 UTC
- Date of event
- 13 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Dellora Investments LP disclosed 1.3% ownership in PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value (PVLA) on 13 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Dec 2024, 16:22.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Dellora Investments Master Fund LP | 1.1% | 123,034 | 0 | 123,034 | /s/ Kevin Pyun | Principal, Dellora Investments Fund GP LLC, its General Partner | |
| Dellora Investments LP | 1.3% | 141,079 | 0 | 141,079 | /s/ Kevin Pyun | Principal, Dellora Investments GP LLC, its General Partner | |
| Kevin Pyun | 1.3% | 141,079 | 0 | 141,079 | /s/ Kevin Pyun | Kevin Pyun |